Interaction of the Gut Microbiome and Immunity in Multiple Sclerosis: Impact of Diet and Immune Therapy
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241914756 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Sudhir Kumar Yadav und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Rutgers-Robert Wood Johnson Medical School, Piscataway, NJ 08854, USA. Hauptthemen laut MEDLINE: Multiple Sclerosis, Gastrointestinal Microbiome, Encephalomyelitis, Autoimmune, Experimental. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 133 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Multiple Sclerosis Society, Ruth Dunietz Kushner and Michael Jay Serwitz endowed Chair, USA National Multiple Sclerosis Society.
Abstract (Originalsprache)
The bidirectional communication between the gut and central nervous system (CNS) through microbiota is known as the microbiota–gut–brain axis. The brain, through the enteric neural innervation and the vagus nerve, influences the gut physiological activities (motility, mucin, and peptide secretion), as well as the development of the mucosal immune system. Conversely, the gut can influence the CNS via intestinal microbiota, its metabolites, and gut-homing immune cells. Growing evidence suggests that gut immunity is critically involved in gut–brain communication during health and diseases, including multiple sclerosis (MS). The gut microbiota can influence the development and function of gut immunity, and conversely, the innate and adaptive mucosal immunity can influence microbiota composition. Gut and systemic immunity, along with gut microbiota, are perturbed in MS. Diet and disease-modifying therapies (DMTs) can affect the composition of the gut microbial community, leading to changes in gut and peripheral immunity, which ultimately affects MS. A high-fat diet is highly associated with gut dysbiosis-mediated inflammation and intestinal permeability, while a high-fiber diet/short-chain fatty acids (SCFAs) can promote the development of Foxp3 Tregs and improvement in intestinal barrier function, which subsequently suppress CNS autoimmunity in the animal model of MS (experimental autoimmune encephalomyelitis or EAE). This review will address the role of gut immunity and its modulation by diet and DMTs via gut microbiota during MS pathophysiology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Rutgers-Robert Wood Johnson Medical School, Piscataway, NJ 08854, USA.
- Rutgers New Jersey Medical School, Newark, NJ 07101, USA.
Förderung
- National Multiple Sclerosis Society
- Ruth Dunietz Kushner and Michael Jay Serwitz endowed Chair
- USA National Multiple Sclerosis Society
- Ruth Dunietz Kushner and Michael Jay Serwitz endowed Chair in Multiple Sclerosis
Zitieren
APA
Yadav, S. K., Ito, K., & Dhib-Jalbut, S. (2023). Interaction of the Gut Microbiome and Immunity in Multiple Sclerosis: Impact of Diet and Immune Therapy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241914756
Vancouver
Yadav SK, Ito K, Dhib-Jalbut S. Interaction of the Gut Microbiome and Immunity in Multiple Sclerosis: Impact of Diet and Immune Therapy. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241914756
BibTeX
@article{Yadav2023,
author = {Yadav, Sudhir Kumar and Ito, Kouichi and Dhib-Jalbut, Suhayl},
title = {Interaction of the Gut Microbiome and Immunity in Multiple Sclerosis: Impact of Diet and Immune Therapy},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241914756}
}
EUVIMED